Latest News: Big Data & Analytics
Discover the latest tips, news and insights from Zephyr Health
Commercial Life Sciences teams must deliver value to their customers, necessitating a forward-looking strategy that embraces data and insights. Here are three approaches essential to any plan for a digital future.
There are exciting opportunities for teams to leverage machine learning and AI to improve everything in their commercial strategies. Leilani Latimer discusses how intelligent data solutions open up new possibilities.
In this PharmaVOICE excerpt, Zephyr Health’s Leilani Latimer outlines how big data and insights allow marketers to build dynamic strategies, and how machine learning enhances such data-driven initiatives.
In this excerpt from our full-length webinar, a Senior Product Manager of a Top 10 medical device company shares how her team increased patient referral sales with commercial analytics.
2018 is the year the Life Sciences must push toward digital transformation. William King, founder and executive chairman of Zephyr Health, looks ahead to new trends and offers five predictions that will be critical for pharma go-to-market strategies.
Big data is dramatically changing how pharma approaches its customers. In this FirstWord webinar and accompanying interview, you’ll discover the key benefits every team can gain from utilizing big data and analytics.
To handle the growing complexity of the healthcare stakeholder ecosystem, commercial teams in the Life Sciences are turning to artificial intelligence and machine learning to save money, integrate data, and reach the right customers.
Networks of relationships are shifting the decision-making process. In this new report, learn how how digital insights on customer networks are critical differentiators for your go-to-market brand initiatives.
Announcing Relationship Analytics: a suite of analytic capabilities designed help to understand and capitalize on HCP and HCO relationships and networks for more effective engagement and decision-making
In this excerpt from Pharmaceutical Executive, we discuss the imperative for pharma to take next steps in tech adoption as we face a new inflection point in the evolution of big data.
In this interview with Pharma Leaders, Zephyr Health President and CEO Lance Scott shares his top 5 things to know about data and insights for Life Sciences companies and their digital transformation strategies.
Medical science liaisons (MSLs) need a wide, objective view of recognized and up-and-coming thought leaders. Integrating different data streams into a single source of the truth provides up-to-date, reliable, and compliant methods of assessing physicians.